Oxford Nanopore Technologies plc (ONTTF)
 OTCMKTS  · Delayed Price · Currency is USD  
1.789
 -0.021 (-1.16%)
  Nov 3, 2025, 3:09 PM EST
ONTTF Revenue
Oxford Nanopore Technologies had revenue of 105.60M GBP in the half year ending June 30, 2025, with 22.79% growth. This brings the company's revenue in the last twelve months to 204.69M, up 22.01% year-over-year. In the year 2024, Oxford Nanopore Technologies had annual revenue of 183.19M with 7.97% growth.
Revenue (ttm) 
 204.69M GBP
Revenue Growth 
 +22.01%
P/S Ratio 
 6.12
Revenue / Employee 
 148.11K GBP
Employees 
 1,382
Market Cap 
1.72B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 183.19M | 13.52M | 7.97% | 
| Dec 31, 2023 | 169.67M | -28.94M | -14.57% | 
| Dec 31, 2022 | 198.60M | 64.94M | 48.59% | 
| Dec 31, 2021 | 133.66M | 19.80M | 17.39% | 
| Dec 31, 2020 | 113.86M | 61.80M | 118.70% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| American Oncology Network | 1.76B | 
| Veradigm | 588.02M | 
| Jushi Holdings | 256.36M | 
| Glass House Brands | 221.55M | 
| Elite Pharmaceuticals | 105.45M | 
| Silence Therapeutics | 27.17M | 
| China New Energy Group Co. | 12.51M | 
| Northwest Biotherapeutics | 1.09M | 
Oxford Nanopore Technologies News
- 19 days ago - Oxford Nanopore Announces PromethION Plus Flow Cell and Human Genetics Updates at ASHG 2025 - Business Wire
 - 26 days ago - Bio-Techne (TECH) Expands Partnership with Oxford Nanopore Technologies - GuruFocus
 - 2 months ago - Half Year 2025 Oxford Nanopore Technologies PLC Earnings Presentation Transcript - GuruFocus
 - 2 months ago - Oxford Nanopore Technologies plc (ONTTF) Q2 2025 Earnings Call Transcript - Seeking Alpha
 - 2 months ago - Oxford Nanopore Technologies plc 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
 - 2 months ago - FTSE Falls as Starmer Resets Government - Investomania
 - 2 months ago - UK Stock Market News: Michelmersh Brick, WizzAir, Oxford Nanopore - The Armchair Trader
 - 3 months ago - ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology - Business Wire